Pacira | PCRX - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Astellas Pharma JPY 186.51B 138.49B 2026-06
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Cara Therapeutics USD -6.8M 1.9M 2026-03
Coherus Biosciences USD -46.35M 90.86M 2025-12
Heron Therapeutics USD -2.95M 14.54M 2025-12
Ironwood Pharmaceuticals USD 68.02M 30.2M 2025-09
J&J USD 8.66B 839M 2026-06
Ligand Pharmaceuticals USD -24.26M 81.04M 2026-03
Nektar Therapeutics USD -43.09M 8.39M 2026-03
Novo Nordisk DKK 33.8B 3.23B 2025-06
Omeros USD -65.12M 21.27M 2024-06
Pacira USD 5M 4.43M 2026-03
Perrigo USD 105.4M 513.9M 2026-06
Pfizer USD -653M 5.84B 2026-06
Supernus Pharmaceuticals USD -57.65M 51.7M 2026-06
Teva Pharmaceutical Industries USD -455M 1.21B 2026-06
Xeris Pharmaceuticals USD 2.23M 8.85M 2026-03
Zoetis USD 758M 3M 2026-03